A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers (NCT07598136)
A Randomized Controlled Trial to Determine the Effect of Flavor Availability on Smoking Abstinence With an Electronic Nicotine Delivery System in Primary Combustible Cigarette Smokers
🩺 Plain-English Summary (8th-Grade Level)
The overall purpose of this study will be to assess primary combustible cigarette users' abstinence from smoking their usual brand of combustible cigarettes at the end of the study, when provided with an electronic nicotine delivery system (ENDS) power unit (2) and varying levels of access to tobacco-flavored, menthol-flavored, mint, or non-tobacco/non-menthol/non-mint-flavored cartridge-based e-liquids (collectively referred to as the investigational product) within their assigned study arm over a three-month (ninety-day) period.
Who can join: Review the eligibility criteria below.
Location: Sago Orlando — Maitland, Florida
Age range: 21 Years to 65 Years
🧪 Interventions in This Study
- P2613422 (OTHER)
- P2611222 (OTHER)
- P2615522 (OTHER)
- P2615122 (OTHER)
- P2615422 (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (7 Sites)
- Sago Orlando — Maitland, Florida
- Sago Atlanta — Atlanta, Georgia
- Sago St. Louis — St Louis, Missouri
- L&E Raleigh — Raleigh, North Carolina
- Sago Philadelphia — Philadelphia, Pennsylvania
- Sago Dallas — Dallas, Texas
- Sago Houston — Houston, Texas
📞 Contact the Study Coordinator
Phone: (336) 741-3761
Email: montgomery_hedgecock@rjrt.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Smoking
- Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study) — Galveston, Texas
- Smartphone-delivered Scheduled Smoking With Compliance Facilitation as an Adjunct Cessation Therapy: a Feasibility Study — Houston, Texas
- The Effect of Tobacco Products on Wound Healing — Minneapolis, Minnesota
- Digitally Enhanced Smoking Cessation for High Risk Smokers — Boston, Massachusetts
- Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava — Gainesville, Florida
- A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer — Basking Ridge, New Jersey
Explore by condition: All Smoking clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.